As part of the execution of Novo Nordisk A/S' DKK 12 billion share repurchase programme for 2011, a new share repurchase programme has been initiated in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.
